Executive Profile

Ruth Devenyns Investment Director, Korys

Age	Total Calculated Compensation	This person is connected to 6 Board Members in 6 different organizations across 12 different industries. See Board Relationships
48	--

Background

Ms. Ruth Devenyns has been an Investment Director of Korys since joining in June 2012, and a primary focuses on life sciences. Ms. Devenyns has a long standing experience in the biotechnology sector. As Analyst and investment banker, she was in charge of the venture capital activities in the sector at KBC Private Equity until end of March 2012. She was an Investment Director of KBC Private Equity NV and was involved in several IPO’s, private placements and merger and ... acquisitions -transactions and held various directorships including Ablynx, Applied Maths, and Pronota. At KBC Private Equity she also managed various investments in agro-biotech and seed companies such as CropDesign and Ceres. Ms. Devenyns served as a Senior Investment Manager at the firm. She joined KBC Bank’s Economic Research Department in 1986 and covered several industries including the chemical and pharmaceutical industry and published numerous articles in KBC Bank’s reputed Economic and Financial Bulletin. In 1992, she moved to KBC Bank’s Corporate Finance Department and was a member of the working group. In 1995, she started up KBC Securities’ equity research team. From 1996 onwards, Ms. Devenyns has specialized in biotechnology initially as an Analyst, later on as the driving force behind KBC Securities’ efforts to build an investment banking franchise in life sciences. She was actively involved in a number of initial public offerings and private placements. In 2001, Ms. Devenyns moved to the buy side and was in charge of managing KBC’s private equity investments in life sciences. She was Equity Analyst at KBC Securities NV, Research Division. She has frequent contacts with senior management people in the industry worldwide and is a regular guest speaker at seminars in Belgium and abroad. She served as the Chairman of Applied Maths NV. She has been an Independent Director of deVGen NV since June 1, 2012. She has been a Director at Altea Therapeutics Corporation since July 28, 2005. She has been a Non-Executive Independent Director of MDxHealth SA (formerly OncoMethylome Sciences) since August 24, 2011 and Devgen. She serves as a Director at FlandersBio and Maize Technologies International GmbH. She serves as Director of Biocartis SA. She served as a Director of Biocartis SA, Ablynx nv since August 23, 2006, Movetis NV since January 8, 2007, and Ceres, Inc. since June 2010. She served as a Director of Pronota NV. Ms. Devenyns received a Masters degree in Applied Economics from Ghent University (RUG) in 1986.

Corporate Headquarters Vaucampslaan 42 Huizingen, Flemish Brabant 1654 Belgium Phone: 32 2 801 68 34 Fax: -- Board Members Memberships Director Altea Therapeutics Corporation Director Maize Technologies International GmbH Former Director Pronota NV Former Chairman Applied Maths NV Former Director Movetis NV Non Executive Director Biocartis SA Direcor FlandersBio 2006-N/A Former Director Ablynx NV 2010-N/A Former Director Ceres, Inc. 2011-Present Non-Executive Independent Director and Chairman of Audit Committee MDxHealth SA 2012-Present Member of The Board of Directors deVGen NV Education Master's Degree 1986 Universiteit Gent Other Affiliations deVGen NV KBC Securities NV Altea Therapeutics Corporation Ceres, Inc. Ablynx NV KBC Private Equity NV MDxHealth SA Universiteit Gent Maize Technologies International GmbH KBC Securities NV, Research Division Pronota NV Applied Maths NV Movetis NV Biocartis SA FlandersBio

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.